GGrantIndex
Sort

85,873 grants matching alzheimers

Peripheral and brain levels of advanced glycation end products AGEs and incident Alzheimers disease and neuropathology

$758,949
Michal Schnaider Beeri · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · AG

Enhanced Mediterranean Diet for Alzheimer's Disease Prevention

$758,906
Debra K Sullivan · University Of Kansas Medical Center · R01 · FY2018 · AG

Increasing successful returns to community living from nursing facilities through the Money Follows the Person program: Mechanisms for improving outcomes for older adults with dementia

$758,885
Ellis C Dillon · University Of Connecticut Sch Of Med/Dnt · R01 · FY2025 · AG

Identifying Alzheimer’s Disease Causal Variants and Target Genes Using iPSC-derived Microglia

$758,870
Douglas H. Phanstiel · Univ Of North Carolina Chapel Hill · R01 · FY2020 · AG

Resource Center for Alzheimer's and Dementia Research in Asian and Pacific Americans

$758,806
William Tzu-Lung Hu · Rutgers Biomedical And Health Sciences · P30 · FY2023 · AG

Glycolysis and rodent models of Alzheimer's disease

$758,745
Qiang Zhang · University Of Iowa · R01 · FY2025 · AG

Blood-Brain Barrier Dysfunction in Alzheimer’s Disease: New Mechanistic Insights and Therapeutic Strategies

$758,744
Anika M.s. Hartz · University Of Kentucky · R01 · FY2025 · AG

Genetic Predictors, Transcriptomic Biomarkers, & Neurobiological Signatures of Resilience to Alzheimer's Disease

$758,687
Stephen J Glatt · Upstate Medical University · R01 · FY2023 · AG

Aerobic Glycolysis: A Marker of BrainResilience to Aging and Alzheimer's Disease

$758,681
Andrei G. Vlassenko · Washington University · R01 · FY2017 · AG

Saracatinib and 1400W Counteract Nerve Agents-Induced Long-Term Neurotoxicity

$758,641
Thimmasettappa Thippeswamy · Iowa State University · U01 · FY2023 · NS

Optimizing Research Infrastructure of Registries to Accelerate Participant Recruitment into Alzheimer's Focused Studies

$758,637
Jessica Brooke Langbaum · Banner Health · R33 · FY2025 · AG

White matter degeneration: biomarkers in preclinical Alzheimer's Disease

$758,631
Barbara Brigitta Bendlin · University Of Wisconsin-Madison · R56 · FY2017 · AG

Towards a better understanding of genetic architecture of Alzheimer's disease with human iPSC models

$758,603
Zhexing Wen · Emory University · R01 · FY2022 · AG

Epidemiology of Familial Late-Onset Alzheimer's Disease

$758,600
Richard Mayeux · Columbia University Health Sciences · R01 · FY2013 · AG

Changes across the lifespan in the use of heuristics to guide decision-making

$758,584
Michele A Basso · University Of California Los Angeles · R01 · FY2019 · AG

Changes across the lifespan in the use of heuristics to guide decision-making

$758,584
Michele A Basso · University Of California Los Angeles · R01 · FY2020 · AG

Involving Family to Improve Advance Care Planning for Primary Care Patients with ADRD

$758,567
Jennifer L Wolff · Johns Hopkins University · R01 · FY2022 · AG

SV2A PET imaging in Alzheimer's Disease

$758,565
Barbara Brigitta Bendlin · University Of Wisconsin-Madison · R01 · FY2018 · AG

Building Biomedical Research Center at VSU

$758,543
W. Weldon Hill · Virginia State University · P20 · FY2008 · MD

Vitamin B12 status, cognitive decline and incident dementia

$758,541
Paul F Jacques · Tufts University Boston · R01 · FY2021 · AG

Improving Outcomes for Family Caregivers and Older Adults with Alzheimer’s Disease and Related Dementias: The Adult Day Service Plus Program

$758,540
Laura N. Gitlin · Johns Hopkins University · R01 · FY2018 · AG

Building Biomedical Research Center at VSU

$758,519
W. Weldon Hill · Virginia State University · P20 · FY2010 · MD

Saracatinib and 1400W Counteract Nerve Agents-Induced Long-Term Neurotoxicity

$758,516
Thimmasettappa Thippeswamy · Iowa State University · U01 · FY2025 · NS

Methods to Test Biomarkers of Aging as Shared Determinants of Alzheimers Disease and Related Dementias and Physical Disability

$758,498
Michelle Denise Shardell · University Of Maryland Baltimore · R01 · FY2024 · AG

Epigenomic analysis of neural circuits in Alzheimer's disease mouse models

$758,446
Xiangmin Xu · University Of California-Irvine · R01 · FY2022 · AG